Funding News Edition: December 02, 2020 See more articles in this edition
NIH seeks input from the general public and stakeholders in the scientific research, advocacy, and clinical practice communities on the NIH-Wide Strategic Plan for COVID-19 Research through the October 28, 2020 Guide notice Request for Information (RFI): Inviting Comments and Suggestions on the NIH-Wide Strategic Plan for COVID-19 Research.
The Strategic Plan, originally released on July 13, 2020, provided a framework to support the tools and approaches needed to better prevent, diagnose, and treat COVID-19. Due to the urgent, constantly evolving nature of the pandemic, NIH will continually update this Strategic Plan to reflect new challenges presented by COVID-19.
This RFI invites comments and suggestions that will inform NIH’s research interests around SARS-CoV-2 and COVID-19. The Strategic Plan outlines NIH’s five priorities, guided by three Crosscutting Strategies, below:
- Priority 1: Improve Fundamental Knowledge of SARS-CoV-2 and COVID-19
- Priority 2: Advance Detection and Diagnosis of COVID-19
- Priority 3: Advance the Treatment of COVID-19
- Priority 4: Improve Prevention of SARS-CoV-2 Infection
- Priority 5: Prevent and Redress Poor COVID-19 Outcomes in Health Disparity and Vulnerable Populations
Refer to the RFI for a set of objectives that support each listed priority.
- Partnering to Promote Collaborative Science
- Supporting the Research Workforce and Infrastructure
- Investing in Data Science
See the RFI for examples of activities to advance each of the identified strategies.
Requests for Comments
Beyond critiquing the priorities and strategies NIH identified in the existing Strategic Plan, you are invited to submit feedback on:
- Significant research gaps or barriers not identified in the existing framework above
- Resources required or lacking or existing leverageable resources (e.g., existing partnerships, collaborations, or infrastructure) that could advance the strategic priorities
- Emerging scientific advances or techniques in basic, diagnostic, therapeutic, or vaccine research that may accelerate the research priorities detailed in the framework above
- Additional ideas for bold, innovative research initiatives, processes, or data-driven approaches that could advance the response to COVID-19
NIH encourages organizations (e.g., patient advocacy groups, professional organizations) to submit a single response reflective of the views of the organization or membership as a whole.
How To Submit a Response
Submit responses electronically through the submission website by 11:59 p.m. Eastern Time on December 7, 2020. Responses to this RFI are voluntary and may be submitted anonymously. Avoid sharing any proprietary, classified, confidential, or sensitive information in your response.
Direct questions to firstname.lastname@example.org.